Summary - Funding Rounds

Founding Date

1991

Investors

Pharmacyclics is a subsidiary of AbbVie

Pharmacyclics Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014

Revenue

160.7m260.2m729.7m

Revenue growth, %

180%

Cost of goods sold

3.5m40.4m

Gross profit

256.7m689.3m

Gross profit Margin, %

99%94%

R&D expense

29.3m85.1m172.5m

General and administrative expense

11.3m104.0m168.0m

Operating expense total

40.6m158.7m566.9m

Depreciation and amortization

520.0k

EBIT

120.1m97.9m122.4m

EBIT margin, %

75%38%17%

Interest expense

Interest income

137.0k341.0k440.0k

Pre tax profit

120.2m98.1m122.4m

Income tax expense

2.6m31.1m36.3m

Net Income

117.5m67.0m86.1m

Pharmacyclics Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014

Cash

307.4m624.0m845.0m

Accounts Receivable

26.7m11.0m64.3m

Prepaid Expenses

2.7m9.3m20.6m

Inventories

12.6m34.4m

Current Assets

346.5m740.8m1.0b

PP&E

6.4m25.5m32.5m

Total Assets

355.1m768.8m1.1b

Accounts Payable

4.6m4.0m7.3m

Current Liabilities

29.3m87.6m194.2m

Total Debt

Total Liabilities

92.6m141.1m230.9m

Common Stock

7.0k7.0k8.0k

Additional Paid-in Capital

546.1m844.2m959.6m

Retained Earnings

(283.6m)(216.6m)(130.5m)

Total Equity

262.5m627.6m829.2m

Financial Leverage

1.4 x1.2 x1.3 x

Pharmacyclics Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014

Net Income

117.5m67.0m86.1m

Depreciation and Amortization

595.0k2.2m4.4m

Accounts Receivable

(20.8m)(11.0m)(53.3m)

Inventories

(12.4m)(21.0m)

Accounts Payable

1.6m(37.0k)3.3m

Cash From Operating Activities

110.7m88.8m183.8m

Purchases of PP&E

(2.4m)(18.3m)(13.9m)

Cash From Investing Activities

(6.4m)(20.3m)(23.4m)

Short-term Borrowings

Cash From Financing Activities

5.2m248.1m60.8m

Net Change in Cash

109.5m316.5m221.1m

Interest Paid

Income Taxes Paid

980.0k820.0k10.4m

Pharmacyclics Ratios

USDQ1, 2012

Financial Leverage

1.2 x

Pharmacyclics Employee Rating

2.6226 votes
Culture & Values
2.8
Work/Life Balance
3.1
Senior Management
2.7
Salary & Benefits
3.2
Career Opportunities
2.8
Source